Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSFOMYCIN TROMETHAMINE vs FREMANEZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSFOMYCIN TROMETHAMINE vs FREMANEZUMAB: Safety Overview

Metric FOSFOMYCIN TROMETHAMINE FREMANEZUMAB
Total FAERS Reports 778 224
Deaths Reported 24 2
Death Rate 3.1% 0.9%
Hospitalizations 280 39
Average Patient Age 59.2 yrs 47.1 yrs
% Female Patients 83.9% 88.8%
FDA Approval Date Dec 19, 1996 N/A
Manufacturer Cipla USA Inc. Teva Pharmaceuticals USA, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Discontinued N/A